![Matthew Bartholomae](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profiel
Matthew Bartholomae is Secretary & General Counsel at Cartesian Therapeutics, Inc. since 2023.
Formerly, Secretary & General Counsel at Selecta Biosciences, Inc. from 2020 to 2023, and Counsel at Minerva Neurosciences, Inc. from 2016 to 2018.
Education includes undergraduate studies at Boston College and graduate studies at the University of New Hampshire School of Law.
Actieve functies van Matthew Bartholomae
| Bedrijven | Functie | Begin |
|---|
Eerdere bekende functies van Matthew Bartholomae
| Bedrijven | Functie | Einde |
|---|---|---|
| CARTESIAN THERAPEUTICS, INC. | Algemeen Adviseur | 01-11-2023 |
| MINERVA NEUROSCIENCES, INC. | Corporate Officer/Principal | 01-01-2018 |
Opleiding van Matthew Bartholomae
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
16
Eerstegraads connecties
4
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
Selecta Biosciences, Inc.
 Selecta Biosciences, Inc. BiotechnologyHealth Technology Develops targeted immunotherapies and vaccines to treat and prevent diseases | Health Technology |
Boston College
 Boston College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Minerva Neurosciences, Inc.
 Minerva Neurosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and commercializes drugs to treat patients suffering from central nervous system diseases | Health Technology |
University of New Hampshire School of Law
 University of New Hampshire School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kies MarketScreener 
